Atlas Trials

Clarithromycin-based Triple Therapy for 14 Days Versus Sequential Therapy 10 Days in the First Line Therapy

Clinical trial NCT01607918 · UNKNOWN

Trial details

NCT number
NCT01607918
Sponsor
National Taiwan University Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Eradication Rates of the Two Regimens
Start date
2012-02-01
Primary completion
2013-12-01
Enrollment
1300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.